Cardiovascular MRI: From Principles to
Protocols
Organizers:
James F.M. Meaney, M.D., Jeanette Schulz-Menger, M.D.
Skill Level: Basic
Overview
This
four-hour course focuses on the application of MR technologies
to clinical problem solving. It will clarify the rapidly
evolving MR techniques applicable to the many demanding
questions posed by clinicians treating disorders of the heart
and blood vessels. Specific issues addressed include the
renewed interest in non-contrast MRA applications against a
background of almost universal acceptance of contrast-enhanced
techniques; the possibility for comprehensive evaluation of the
heart and pulmonary vasculature in patients with pulmonary
hypertension; resurgence of the issues of increased speed to
eliminate venous enhancement in peripheral MRA in the face of
recent introduction of “blood-pool” contrast agents (in Europe);
and assessment of acute and chronic coronary syndromes; and
evaluation of non-ischemic heart disease.
Educational
Objectives
Upon
completion of this course, participants should be able to:
•
Clarify the current status of the many competing
cutting-edge MR technologies for evaluation of the heart and
blood vessels;
•
Describe a comprehensive MR protocol for evaluation of
patients with pulmonary hypertension;
•
Demonstrate a robust protocol for evaluation of coronary
ischaemia, and present a tailored easily Implemented method
for determination of myocardial viability and function;
•
Compare the currently available contrast agents for
first-pass imaging and describe similarities and differences
between these
agents and blood pool agents; and
•
Appraise the potential role of current and future
developments in pulse-sequences, hardware and contrast
agents that will
address some of the existing limitations.
Audience
Description
This course
is designed for attendees who want to improve their
understanding of CV diagnosis, and will be of interest to
technologists, basic scientists, radiologists and cardiologists.
A basic understanding of disease processes or MR technology or
both would be helpful, although the course is also suitable for
those with little prior experience of CV MRI as a primer. Most
attendees will likely have some experience of either direct
patient care, execution of CV protocols within the MR
environment and some knowledge of the direction of CV research.
|
The final five minutes of each talk will be reserved for
questions. |
|
|
|
|
|
Tuesday, 22 May |
|
|
Cardiac: Coronary Artery Disease |
|
07:00 |
Assessment of Ischemia - ready for clinical routine
(wall motion or adenosine |
Jürg Schwitter, M.D. |
|
first pass perfusion) |
|
07:20 |
Detection of Acute und Chronic Myocardial Infarction -
only of scientific value |
Matthias G. Friedrich, M.D. |
07:40 |
Assessment of Viability (Contrast Enhancment or/and
Wallmotion) |
Victor A. Ferrari, M.D. |
08:00 |
Adjournment |
|
|
|
|
|
|
|
|
|
Wednesday, 23 May |
|
|
Vascular. From Non-contrast to Contrast-enhanced MRA |
|
07:00 |
Current status & Theoretical limits |
Stephen J. Riederer, Ph.D. |
07:20 |
Current and novel Contrast agents for MRA |
Mike V. Knopp, M.D. |
07:40 |
Remaining clinical limitations of MRA |
Stefan O. Schoenberg, M.D. |
08:00 |
Adjournment |
|
|
|
|
|
|
|
|
|
Thursday, 24 May |
|
|
Cardiac: Non Ischemic Heart Disease |
|
07:00 |
Cardiomyopathies - added information applying CMR? |
David A. Bluemke, M.D., Ph.D. |
07:20 |
Inflammatory Heart Disease and Myocardial Involvement in
Systemic Disorders |
Sanjay Prasad, M.D. |
07:40 |
Aquired valvular disease - space for CMR? |
Andrew E. Arai, M.D. |
08:00 |
Adjournment |
|
|
|
|
|
|
|
|
|
Friday, 25 May |
|
|
Vascular - Pulmonary and peripheral arteries |
|
07:00 |
Pulmonary hypertension Combined MRA, perfusion,
myocardial function |
Konstantin Nikolaou, M.D. |
07:30 |
Venous contamination in peripheral MRA Increased speed,
tourniquets or both |
Martin R. Prince, M.D., Ph.D. |
08:00 |
Adjournment |
|
|
|